Canrenoate potassium

坎利酸钾

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCanrenoate potassium
Drug Alias Name烯睾丙酸钾Potassium Canrenoate6-去氢睾酮-17-丙酸钾SoldactoneMF-465a +[6
ClassificationSmall molecules > Steroids
Mechanisms of ActionAldosterone antagonists
TargetsAldosterone
Therapy Area/IndicationsEdemaRespiratory Distress Syndrome, Adult
Global Approved IndicationsEdema
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1967/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsEdema
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeC03DA02